Rapid assessment of the risk of SARS-CoV-2 importation: case study and lessons learned

During the early stages of an emerging disease outbreak, governments are required to make critical decisions on how to respond, despite limited data being available to inform these decisions. Analytical risk assessment is a valuable approach to guide decision-making on travel restrictions and border...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epidemics 2022-03, Vol.38, p.100549-100549, Article 100549
Hauptverfasser: Shearer, Freya M., Walker, Camelia R., Tellioglu, Nefel, McCaw, James M., McVernon, Jodie, Black, Andrew, Geard, Nicholas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:During the early stages of an emerging disease outbreak, governments are required to make critical decisions on how to respond, despite limited data being available to inform these decisions. Analytical risk assessment is a valuable approach to guide decision-making on travel restrictions and border measures during the early phase of an outbreak. Here we describe a rapid risk assessment framework that was developed in February 2020 to support time-critical decisions on the risk of SARS-CoV-2 importation into Australia. We briefly describe the context in which our framework was developed, the framework itself, and provide an example of the type of decision support provided to the Australian government. We then report a critical evaluation of the modelling choices made in February 2020, assessing the impact of our assumptions on estimated rates of importation, and provide a summary of “lessons learned”. The framework presented and evaluated here provides a flexible approach to rapid assessment of importation risk, of relevance to current and future pandemic scenarios. •Rapid decision making is needed during emerging disease outbreaks.•We describe a flexible framework used for rapid risk assessment of importation risk.•Our framework was used to provide timely and transparent advice about SARS-CoV-2.•We evaluate assumptions made by our framework as a guide to future use.
ISSN:1755-4365
1878-0067
1878-0067
DOI:10.1016/j.epidem.2022.100549